Literature DB >> 1003542

Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells.

G M Hahn, D P Strande.   

Abstract

Chinese hamster cells, exposed to simultaneous hyperthermia (43 degrees C) and adriamycin (ADM), were intially sensitized to the cytotoxic activity of ADM. If the duration of the combined treatment exceeded about 30 minutes, however, the cells became refractory to additional killing by ADM. If heat was applied before ADM exposure, the cells also could be rendered insensitive; this state persisted so that 24 hours after a 50-minute exposure to 43 degrees C, the cells still showed considerable resistance to ADM. The most reasonable explanation for the findings was that cell membrane permeability to ADM was initially increased by hyperthermia, but prolonged (greater than 30 min) heat exposure reversed this situation and inhibited additional ADM from penetrating to sensitive sites. However, the data yield no hints as to the precise mechanisms involved nor are they sufficiently precise to exclude other explanations. The results do point to precautions that must be observed if the combination of ADM and hyperthermia is to be used clinically.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003542     DOI: 10.1093/jnci/57.5.1063

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  19 in total

1.  Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response.

Authors:  J W Shen; J R Subjeck; R B Lock; W E Ross
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

2.  Enhanced chemosensitivity of cells from malignant effusions under condition of exposure to high temperature.

Authors:  T Akiyoshi; T Wada; S Arinaga; F Koba; H Tsuji
Journal:  Jpn J Surg       Date:  1986-09

Review 3.  Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes.

Authors:  Mark W Dewhirst; Chelsea D Landon; Christina L Hofmann; Paul R Stauffer
Journal:  Surg Oncol Clin N Am       Date:  2013-03-13       Impact factor: 3.495

Review 4.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Modulation of adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting.

Authors:  G C Rice; G M Hahn
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 6.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

7.  Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells.

Authors:  S Ohno; Z H Siddik; Y Kido; L A Zwelling; J M Bull
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Ultrasound-induced mild hyperthermia as a novel approach to increase drug uptake in brain microvessel endothelial cells.

Authors:  Cheong-Weon Cho; Yang Liu; Wesley N Cobb; Thomas K Henthorn; Kevin Lillehei; Uwe Christians; Ka-Yun Ng
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

9.  Laser flow cytometric studies on the intracellular accumulation of anthracyclines when combined with heat.

Authors:  Y Sakaguchi; Y Maehara; S Inutsuka; I Takahashi; M Yoshida; Y Emi; H Baba; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Sensitivity to thermochemotherapy of AKR lymphoma and B16 melanoma variants of malignancy.

Authors:  J Leibovici; G Klorin; M Huszar; S Hoenig; O Klein; M Michowitz; A Pinchassov
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.